LOS ANGELES, March 10, 2011 /PRNewswire/ -- InstaCare Corp. (OTC Bulletin Board: ISCR), a leading provider of prescription drugs, home testing products for the chronically ill, a leading fulfillment provider of direct to patient diabetes programs, and a leading developer of revolutionary patent pending cell phone centric e-health products and technologies, announced today that it is ready to ship its new pharmaceutical e-detailing Mobile Health Media System, known as MD@Detail.
The Company is also in serious, high-level discussions with two large pharmaceutical firms and a smart phone provider for strategic partnerships whereby physicians would receive the iPad free of charge in return for a subscription to the e-detailing media service. This model is currently widely in use in the prescription detailing market. InstaCare will be paid fees by the e-detailing sponsor to distribute the e-detailing media content.
Keith Berman, Secretary and CFO of InstaCare commented, "We have received inquiry from three large parties that already have a stake in the $3 billion pharma e-detailing (advertising) marketplace. All three of these companies have special needs and have determined that to move to the head of the pack they will need to better merchandise their messages. InstaCare's MD@Detail is immediately available and the Company expects to move quickly to completed partnership agreements."
About MD@Hand, MD@Work and MD@DetailInstaCare's MD@ technologies allow physicians to gain access to and securely store immediate and critical patient information on smart cell phones, tablet and/or handheld computers and other hybrid mobile devices. The Company believes that no other technology platform provides a physician a suite of robust, secure internet based Electronic Medical Records (EMR) applications, patient medical history applications, and proposed treatment protocols on a popular smart phone platform, with minimal training requirements such as offered by InstaCare.
Forward-Looking StatementsForward-looking statements are statements made herein which do not address historical facts and, therefore could be interpreted to be forward-looking statements. We can give no assurance that the expectations indicated by such forward-looking statements will be realized. There may be other risks and circumstances that we are unable to predict. When used in this release, words such as "believes," "expects," "forecasts," "intends," "projects," "plans," "anticipates," "estimates" and similar expressions are intended to identify forward-looking statements, although there may be certain statements not accompanied by such expressions. All forward-looking statements are intended to be covered by the safe harbor created by Section 21E of the Securities Exchange Act of 1934. Such statements are subject to factors that could cause actual results to differ materially from anticipated results. The forward-looking statements included in this press release represent our views as of March 9, 2011. We anticipate that subsequent events and developments will cause our views to change.
For more information about InstaCare Corp. and its revolutionary MD@Hand and MD@Work cell phone centric technologies, its new MD@Detail pharma media e-detailing product, or Genstrip, please visit the InstaCare web site www.instacare.net or www.pharmatechdirect.com, or contact the Company at (805) 446-2973.Contact: Keith Berman, Secretary and CFOinfo@instacare.net2660 Townsgate Road Suite 300 Westlake Village, CA 91361Ph : 805-446-1973 Fax: 805-446-1983
|SOURCE InstaCare Corp.|
Copyright©2010 PR Newswire.
All rights reserved